Showing 1 - 3 results of 3 for search 'Annemarie Voss', query time: 0.02s Refine Results
  1. 1
    Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands

    Time Trends in Patient Characteristics of New Rivaroxaban Users with Atrial Fibrillation in Germany and the Netherlands by Annemarie Voss, Elisabeth Smits, Karin M. A. Swart, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Ron M. C. Herings, Tania Schink, Ulrike Haug

    Published 2023-02-01
    Get full text
    Article
  2. 2
    Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries.

    Safety profile of rivaroxaban in first-time users treated for venous thromboembolism in four European countries. by Ana Ruigómez, Tania Schink, Annemarie Voss, Ron M C Herings, Elisabeth Smits, Karin Swart-Polinder, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Luis Alberto García Rodríguez

    Published 2024-01-01
    Get full text
    Article
  3. 3
    Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe

    Challenges and lessons learned from a long-term postauthorisation safety study programme of rivaroxaban in Europe by Luis Alberto García Rodríguez, Montse Soriano-Gabarró, Pareen Vora, Yanina Balabanova, Gunnar Brobert, Kiliana Suzart-Woischnik, Ana Ruigomez, Leif Friberg, Ron Herings, Karin M A Swart, Tania Schink, Elisabeth Smits, Annemarie Voss, Christine Tarenz, Martin Homering, Tomasz Dyszynski, Gerd Nagel, Pablo Amaya

    Published 2024-03-01
    Get full text
    Article

Search Tools: